|
PANK2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.58230000000004E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62978999999064E-05 |
| Normal-vs-Stage2 |
5.818400E-02 |
| Normal-vs-Stage3 |
4.848300E-04 |
| Normal-vs-Stage4 |
1.269790E-02 |
| Stage1-vs-Stage2 |
4.115000E-01 |
| Stage1-vs-Stage3 |
9.321600E-01 |
| Stage1-vs-Stage4 |
1.439170E-01 |
| Stage2-vs-Stage3 |
4.556000E-01 |
| Stage2-vs-Stage4 |
8.695800E-01 |
| Stage3-vs-Stage4 |
2.221400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.82500000000174E-05 |
| Normal-vs-AfricanAmerican |
5.099200E-03 |
| Normal-vs-Asian |
1.200650E-03 |
| Caucasian-vs-AfricanAmerican |
4.612000E-01 |
| Caucasian-vs-Asian |
9.221000E-01 |
| AfricanAmerican-vs-Asian |
4.803400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.759100E-04 |
| Normal-vs-Female |
1.56395999999503E-05 |
| Male-vs-Female |
6.626000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.74069999999893E-05 |
| Normal-vs-Age(41-60Yrs) |
1.203510E-04 |
| Normal-vs-Age(61-80Yrs) |
3.183700E-03 |
| Normal-vs-Age(81-100Yrs) |
5.425200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.405400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.592600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.039800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.195400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.886200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.790600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.031800E-01 |
| Classical-VS-Follicular |
5.162200E-02 |
| Classical-VS-Other |
8.158300E-02 |
| Classical-VS-Normal |
7.66009999875195E-08 |
| Tall-VS-Follicular |
4.921200E-01 |
| Tall-VS-Other |
2.401600E-01 |
| Tall-VS-Normal |
1.163860E-02 |
| Follicular-VS-Other |
6.274600E-01 |
| Follicular-VS-Normal |
1.338440E-01 |
| Other-VS-Normal |
9.777200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.635400E-04 |
| Normal-vs-N1 |
1.692830E-01 |
| N0-vs-N1 |
1.331980E-01 |
|
|
